FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 261

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
MBIO Nasdaq Mustang Bio, Inc. 2830
MDGL Nasdaq Madrigal Pharmaceuticals, Inc. 2830
MDWD Nasdaq MediWound Ltd. 2830
MESO Nasdaq Mesoblast Limited 2830
MGRX Nasdaq Mangoceuticals, Inc. 2830
MGTX Nasdaq MeiraGTx Holdings plc 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MLYS Nasdaq Mineralys Therapeutics, Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MPLT Nasdaq MapLight Therapeutics, Inc. 2830
MRKR Nasdaq Marker Therapeutics, Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MSLE Nasdaq Satellos Bioscience Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NAMS Nasdaq NewAmsterdam Pharma Company N.V. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NCNA Nasdaq NuCana plc 2830
NRSN Nasdaq NeuroSense Therapeutics Ltd. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NTRB Nasdaq Nutriband Inc. 2830
NUVB New York Nuvation Bio Inc. 2830
NUVL Nasdaq Nuvalent, Inc. 2830
NVO New York Novo Nordisk A/S 2830
OGEN NYSE American Oragenics, Inc. 2830
OGI Nasdaq Organigram Global Inc. 2830
ONCO Nasdaq Onconetix, Inc. 2830
OPK Nasdaq OPKO Health, Inc. 2830
OVID Nasdaq Ovid Therapeutics Inc. 2830
PALI Nasdaq Palisade Bio, Inc. 2830
PASG Nasdaq Passage Bio, Inc. 2830
PBH New York Prestige Consumer Healthcare Inc. 2830
PBM Nasdaq Psyence Biomedical Ltd. 2830
PBYI Nasdaq Puma Biotechnology, Inc. 2830
PDSB Nasdaq PDS Biotechnology Corporation 2830
PHAR Nasdaq Pharming Group N.V. 2830
PHAT Nasdaq Phathom Pharmaceuticals, Inc. 2830
PHVS Nasdaq Pharvaris N.V. 2830
PMCB Nasdaq PharmaCyte Biotech, Inc. 2830
PMN Nasdaq ProMIS Neurosciences, Inc. 2830
PMVP Nasdaq PMV Pharmaceuticals, Inc. 2830
PPBT Nasdaq Purple Biotech Ltd 2830
PPCB Nasdaq Propanc Biopharma, Inc. 2830
PRAX Nasdaq Praxis Precision Medicines, Inc. 2830
PRFX Nasdaq PRF Technologies Ltd. 2830
PRTA Nasdaq Prothena Corporation plc 2830
PYXS Nasdaq Pyxis Oncology, Inc. 2830
QCLS Nasdaq Q/C Technologies, Inc. 2830
QNTM Nasdaq Quantum BioPharma Ltd. 2830
QTRX Nasdaq Quanterix Corporation 2830
Results 150 through 200 of 261